Recursion Provides Business Updates and Reports Fourth : vim

Initiated five clinical trials in 2022, including three Phase 2 programs, and provided guidance on the timing of clinical data readoutsDelivered against...

Related Keywords

Montreal , Quebec , Canada , Salt Lake City , Utah , United States , Toronto , Ontario , Chris Gibson , Development Expenses , Recursion Pharmaceuticals Inc , Chemical Technology , Recursion Co , Cavernous Malformation , Adenomatous Polyposis , Proficient Ovarian Cancer , Target Gamma , Inhibiting Novel Targets , Target Alpha , Tissue Culturing , Available Dataset , Recursion Co Founder , Download Day , Shareholder Meeting , Recursion Annual Shareholder Meeting , Fiscal Year , Administrative Expenses , San Francisco Bay , Recursion Pharmaceuticals , Biotechnology , Health Pharmaceuticals , Inance Biotech Industry , Technology General ,